livemint.com
85%
735
Covid-19 vaccine: Pfizer, BioNTech start combined clinical trials in Japan
mRNA vaccine candidate against the coronavirus in Japan.The study will recruit 160 people aged from 20 to 85, the firms said in a statement. Earlier, they had agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, reported Reuters.Pfizer, which is developing the vaccine with German partner BioNTech, has said it may confirm if the vaccine is effective as soon as this month, but also needs safety data from a global trial of 44,000 people that will not be available until next month.Moreover, Pfizer had earlier said that it could file in late November for U.S.